Eicosanoids and the Kidney

Seldin and Giebisch's The Kidney: Physiology & Pathophysiology 1-2

Volumn , Issue , 2007, Pages 359-384

  McGiff, John C ^a   Ferreri, Nicholas R ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884846393     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088488-9.50017-6     Document Type: Chapter

References (261)

1. Abdullah H.I., Pedraza P.L., Hao S., et al. NFAT regulates calcium sensing receptor-mediated TNF production. Am J Physiol Renal Physiol 2005.
2. Alonso Galicia M., Drummond H.A., Reddy K.K., et al. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 1997, 29:320-325.
3. Anderson R.J., Berl T., McDonald K.D., et al. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest 1975, 56:420-426.
4. Armstrong J.M., Blackwell G.J., Flower R.J., et al. Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature 1976, 260:582-586.
5. Askari B., Bell-Quilley C.P., Fulton D., et al. Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia. J Pharmacol Exp Ther 1997, 282:101-107.
6. + exchanger isoforms and their regulation by thyroid hormone. Am J Physiol 1996, 270:C585-C592.
7. Baud L., Oudinet J.P., Bens M., et al. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989, 35:1111-1118.
8. Beck L.H. Changes in renal function with aging. Clin Geriatr Med 1998, 14:199-209.
9. Beierwaltes W.H., Schryver S., Sanders E., et al. Renin release selectively stimulated by prostaglandin I2 in isolated rat glomeruli. Am J Physiol 1982, 243:F276-F283.
10. Bergstrom S. Isolation, structure and action of the prostaglandins. Prostaglandins: Proceedings of the Second Nobel Symposium 1966, 21-30. John Wiley & Sons, New York. S. Bergstrom, B. Samuelsson (Eds.).
11. Bohman S.O. Demonstration of prostaglandin synthesis in collecting duct cells and other cell types of the rabbit renal medulla. Prostaglandins 1977, 14:729-744.
12. Bombardier C., Laine L., Reicin A., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000, 343:1520-1528.
13. Bombardier C., Laine L., Reicin A., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000, 343:2.
14. Bonvalet J.P., Pradelles P., Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 1987, 253:F377-F387.
15. Brater D.C. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999, 107:65S-70S.
16. Bresnahan B.A., Wu S., Fenoy F.J., et al. Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids. J Clin Invest 1992, 90:2304-2312.
17. Breyer M.D., Breyer R.M. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 2000, 279:F12-F23.
18. Briggs J.P., Schnermann J. The tubuloglomerular feedback mechanism: functional and biochemical aspects. Annu Rev Physiol 1987, 49:251-273.
19. Bunting S., Gryglewski R., Moncada S., et al. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 1976, 12:897-913.
20. Bunting S., Moncada S., Vane J.R. The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull 1983, 39:271-276.
21. Burns K.D., Capdevila J., Wei S., et al. Role of cytochrome P-450 epoxygenase metabolites in EGF signaling in renal proximal tubule. Am J Physiol 1995, 269:C831-C840.
22. Campbell W.B., Gebremedhin D., Pratt P.F., et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996, 78:415-423.
23. Capdevila J., Chacos N., Werringloer J., et al. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc Natl Acad Sci U S A 1981, 78:5362-5366.
24. Carroll M.A., Balazy M., Huang D.D., et al. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int 1997, 51:1696-1702.
25. Carroll M.A., Balazy M., Margiotta P., et al. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem 1993, 268:12260-12266.
26. Carroll M.A., Balazy M., Margiotta P., et al. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol 1996, 271:R863-R869.
27. Carroll M.A., Garcia M.P., Falck J.R., et al. 5,6-epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ Res 1990, 67:1082-1088.
28. Carroll M.A., Garcia M.P., Falck J.R., et al. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J Pharmacol Exp Ther 1992, 260:104-109.
29. Carroll M.A., Sala A., Dunn C.E., et al. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J Biol Chem 1991, 266:12306-12312.
30. Carroll M.A., Schwartzman M., Capdevila J., et al. Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol 1987, 138:281-283.
31. Cashman J.R., Hanks D., Weiner R.I. Epoxy derivatives of arachidonic acid are potent stimulators of prolactin secretion. Neuroendocrinology 1987, 46:246-251.
32. Castellani S., Paniccia R., Di Serio C., et al. Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure. J Am Coll Cardiol 2003, 42:133-139.
33. Catella-Lawson F., McAdam B., Morrison B.W., et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 1999, 289:735-741.
34. Chacos N., Capdevila J., Falck J.R., et al. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch Biochem Biophys 1983, 223:639-648.
35. Cheng H.F., Wang J.L., Zhang M.Z., et al. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 1999, 103:953-961.
36. Cheng M.K., Doumad A.B., Jiang H., et al. Epoxyeicosatrienoic acids mediate adenosineinduced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. Br J Pharmacol 2004, 141:441-448.
37. Cheng M.K., McGiff J.C., Carroll M.A. Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase. Am J Physiol Renal Physiol 2003, 284:F474-F479.
38. Ciabattoni G., Pugliese F., Cinotti G.A., et al. Characterization of furosemide-induced activation of the renal prostaglandin system. Eur J Pharmacol 1979, 60:181-187.
39. Cowart L.A., Wei S., Hsu M.H., et al. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem 2002, 277:35105-35112.
40. Croft K.D., McGiff J.C., Sanchez-Mendoza A., et al. Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol 2000, 279:F544-F551.
41. Cunningham P.N., Dyanov H.M., Park P., et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002, 168:5817-5823.
42. Daniels E.G., Hinman J.W., Leach B.E., et al. Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla. Nature 1967, 215:1298-1299.
43. dos Santos E.A., Dahly-Vernon A.J., Hoagland K.M., et al. Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis. Am J Physiol Regul Integr Comp Physiol 2004, 287:R58-R68.
44. Dumoulin M., Salvail D., Gaudreault S.B., et al. Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels. Am J Physiol 1998, 275:L423-L431.
45. Endou H. Distribution and some characteristics of cytochrome P-450 in the kidney. J Toxicol Sci 1983, 8:165-176.
46. Epstein M., Berk D.P., Hollenberg N.K., et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970, 49:175-185.
47. Escalante B., Erlij D., Falck J.R., et al. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 1991, 251:799-802.
48. +-K+-ATPase. Biochem Biophys Res Commun 1988, 152:1269-1274.
49. Escalante B., Sessa W.C., Falck J.R., et al. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J Pharmacol Exp Ther 1989, 248:229-232.
50. Escalante B.A., McGiff J.C., Oyekan A.O. Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule. Am J Physiol Renal Physiol 2002, 282:F144-F150.
51. Ferreira S.H., Vane J.R. Prostaglandins: their disappearance from and release into the circulation. Nature 1967, 216:868-873.
52. Ferreri N.R., Schwartzman M., Ibraham N.G., et al. Arachidonic acid metabolism in a cell suspension isolated from rabbit renal outer medulla. J Pharmacol Exp Ther 1984, 231:441-448.
53. Ferreri N.R., Zhao Y., Takizawa H., et al. Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressure. J Hypertens 1997, 15:1481-1484.
54. Fisslthaler B., Popp R., Kiss L., et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999, 401:493-497.
55. Frolich J.C., Wilson T.W., Sweetman B.J., et al. Urinary prostaglandins. Identification and origin. J Clin Invest 1975, 55:763-770.
56. Fujino T., Nakagawa N., Yuhki K., et al. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. J Clin Invest 2004, 114:805-812.
57. Fulton D., McGiff J.C., Quilley J. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the. J Pharmacol Exp Ther 1998, 287:497-503.
58. Fuson A.L., Komlosi P., Unlap T.M., et al. Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney. Am J Physiol Renal Physiol 2003, 285:F558-F564.
59. Ganguli M., Tobian L., Azar S., et al. Evidence that prostaglandin synthesis inhibitors increase the concentration of sodium and chloride in rat renal medulla. Circ Res 1977, 40:I135-I139.
60. Gill J.R., Frolich J.C., Bowden R.E., et al. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med 1976, 61:43-51.
61. Gimbrone M.A., Topper J.N., Nagel T., et al. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000, 902:230-239.
62. Goodwin D.C., Landino L.M., Marnett L.J. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J 1999, 13:1121-1136.
63. Granstrom E., Samuelsson B. Quantitative measurement of prostaglandins and thromboxanes: general considerations. Advances in Prostaglandin and Thromboxane Research 1978, 1-13. Raven Press, New York. B. Samuelsson, P.R. Ramwell, R. Paoletti (Eds.).
64. Grantham J.J., Orloff J. Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3',5'-monophosphate, and theophylline. J Clin Invest 1968, 47:1154-1161.
65. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 1975, 72:2994-2998.
66. Harris R.C., McKanna J.A., Akai Y., et al. Cyclooxygenase-2 is associated with the maculadensa of rat kidney and increases with salt restriction. J Clin Invest 1994, 94:2504-2510.
67. Hasko G., Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004, 25:33-39.
68. Hassid A., Konieczkowski M., Dunn M.J. Prostaglandin synthesis in isolated rat kidney glomeruli. Proc Natl Acad Sci U S A 1979, 76:1155-1159.
69. Henning S.J. Plasma concentrations of total and free corticosterone during development in the rat. Am J Physiol 1978, 235:E451-E456.
70. Hill E., Fitzpatrick F., Murphy R.C. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br J Pharmacol 1992, 106:267-274.
71. Hiller G., Sundler R. Activation of arachidonate release and cytosolic phospholipase A2 via extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in macrop stimulated by bacteria or zymosan. Cell Signal 1999, 11:863-869.
72. Hocherl K., Dreher F., Vitzthum H., et al. Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol 2002, 13:2427-2436.
73. Hockel G.M., Cowley A.W. Prostaglandin E2-induced hypertension in conscious dogs. Am J Physiol 1979, 237:H449-H454.
74. Holla V.R., Adas F., Imig J.D., et al. Alterations in the regulation of androgen-sensitive CYP 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 2001, 98:5211-5216.
75. Holla V.R., Makita K., Zaphiropoulos P.G., et al. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest 1999, 104:751-760.
76. Imanishi M., Kawamura M., Akabane S., et al. Aspirin lowers blood pressure in patients with renovascular hypertension. Hypertension 1989, 14:461-468.
77. Imig J.D. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 2000, 279:F965-F981.
78. Imig J.D. 20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis?. Am J Physiol Regul Integr Comp Physiol 2004, 287:R3-R5.
79. Imig J.D., Falck J.R., Inscho E.W. Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness. Br J Pharmacol 1999, 127:1399-1405.
80. Imig J.D., Navar L.G. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am J Physiol 1996, 271:F87-F93.
81. Imig J.D., Navar L.G., Roman R.J., et al. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 1996, 7:2364-2370.
82. Imig J.D., Zou A.P., Stec D.E., et al. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 1996, 270:R217-R227.
83. Ito O., Alonso G.M., Hopp K.A., et al. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol 1998, 274:F395-F404.
84. Ito O., Roman R.J. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. Hypertension 1999, 33:419-423.
85. Itskovitz H.D., Stemper J., Pacholczyk D., et al. Renal prostaglandins: determinants of intrarenal distribution of blood flow in the dog. Clin Sci Mol Med Suppl 1973, 45(Suppl 1):321s-324s.
86. Itskovitz H.D., Terragno N.A., McGiff J.C. Effect of a renal prostaglandin on distribution of blood flow in the isolated canine kidney. Circ Res 1974, 34:770-776.
87. Jackson E.K., Oates J.A., Branch R.A. Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation. Circ Res 1981, 49:180-185.
88. Jacobson H.R., Corona S., Capdevila J., et al. Effects of epoxyeicostrienoic acids on ion transport in the rabbit cortical collecting tubule. Prostaglandins and Membrane Ion Transport 1984, 311-318. Raven Press, New York. P. Braquet (Ed.).
89. Jensen B.L., Schmid C., Kurtz A. Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol 1996, 271:F659-F669.
90. Jiang H., McGiff J.C., Quilley J., et al. Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells. J Biol Chem 2004, 279:36412-36418.
91. Junier M.P., Dray F., Blair I., et al. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. Endocrinology 1990, 126:1534-1540.
92. Kennedy C.R., Zhang Y., Brandon S., et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med 1999, 5:217-220.
93. Kieran N.E., Maderna P., Godson C. Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney Int 2004, 65:1145-1154.
94. Kim S.F., Huri D.A., Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005, 310:1966-1970.
95. Kim Y.S., Xu Z.G., Reddy M.A., et al. Novel interactions between TGF-1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol 2005, 16:352-362.
96. Kincaid-Smith P. Effects of non-narcotic analgesics on the kidney. Drugs 1986, 32(Suppl 4):109-128.
97. King A.J., Brenner B.M., Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989, 256:F1051-F1058.
98. Kirschenbaum M.A., Lowe A.G., Trizna W., et al. Regulation of vasopressin action by prostaglandins. Evidence for prostaglandin synthesis in the rabbit cortical collecting tubule. J Clin Invest 1982, 70:1193-1204.
99. Komers R., Lindsley J.N., Oyama T.T., et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 2001, 107:889-898.
100. Kroetz D.L., Huse L.M., Thuresson A., et al. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol Pharmacol 1997, 52:362-372.
101. Laethem R.M., Balazy M., Falck J.R., et al. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem 1993, 268:12912-12918.
102. Laffer C.L., Laniado-Schwartzman M., Wang M.H., et al. 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension. Hypertension 2003, 41:703-708.
103. Langenbach R., Morham S.G., Tiano H.F., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995, 83:483-492.
104. Larsson C., Anggard E. Regional differences in the formation and metabolism of prostaglandins in the rabbit kidney. Eur J Pharmacol 1973, 21:30-36.
105. Ledent C., Vaugeois J.M., Schiffmann S.N., et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997, 388:674-678.
106. Lee J.B. Chemical and physiological properties of renal prostaglandins: the antihypertensive effects of medullin in essential human hypertension. Prostaglandins: Proceedings of the Second Nobel Symposium 1966, 197-210. John Wiley & Sons, New York. S. Bergstrom, B. Samuelsson (Eds.).
107. Lee J.B., Crowshaw K., Takman B.H., et al. Identification of prostaglandins E2, F2a and A2 from rabbit kidney medulla. Biochem J 1967, 105:1251-1260.
108. Liclican E.L., McGiff J.C., Pedraza P.L., et al. Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids. Am J Physiol Renal Physiol 2005, 289:F386-F392.
109. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
110. Liu H.J., Wei Y., Ferreri N.R., et al. Vasopressin and PGE(2) regulate activity of apical 70 pS K(+) channel in thick ascending limb of rat kidney. Am J Physiol Cell Physiol 2000, 278:C905-C913.
111. Lu M., Zhu Y., Balazy M., et al. Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney. J Gen Physiol 1996, 108:537-547.
112. Ma Y.H., Harder D.R., Clark J.E., et al. Effects of 12-HETE on isolated dog renal arcuate arteries. Am J Physiol 1991, 261:H451-H456.
113. Macica C.M., Escalante B.A., Conners M.S., et al. TNF production by the medullary thick ascending limb of Henle's loop. Kidney Int 1994, 46:113-121.
114. Makita K., Takahashi K., Karara A., et al. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 1994, 94:2414-2420.
115. Mangat H., Peterson L.N., Burns K.D. Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors. J Clin Invest 1997, 100:1941-1950.
116. Mann B., Hartner A., Jensen B.L., et al. Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 2001, 59:62-68.
117. Martinez-Maldonado M., Gely R., Tapia E., et al. Role of macula densa in diuretics-induced renin release. Hypertension 1990, 16:261-268.
118. McAdam B.F., Catella-Lawson F., Mardini I.A., et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 1999, 96:272-277.
119. McCarron D.A. Diet and blood pressure-the paradigm shift. Science 1998, 281:933-934.
120. McGiff J.C. Bartter's syndrome results from an imbalance of vasoactive hormones. Ann Intern Med 1977, 87:369-372.
121. McGiff J.C. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 1991, 31:339-369.
122. McGiff J.C., Crowshaw K., Terragno N.A., et al. Renal prostaglandins: possible regulators of the renal actions of pressor hormones. Nature 1970, 227:1255-1257.
123. McGiff J.C., Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol 1999, 277:R607-R623.
124. McGiff J.C., Quilley J. 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 2001, 10:231-237.
125. McGiff J.C., Terragno N.A., Malik K.U., et al. Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 1972, 31:36-43.
126. McGiff J.C., Terragno N.A., Strand J.C., et al. Selective passage of prostaglandins across the lung. Nature 1969, 223:742-745.
127. McGuire J.C., Sun F.F. Metabolism of prostacyclin. Oxidation by rhesus monkey lung 15-hydroxyl prostaglandin dehydrogenase. Arch Biochem Biophys 1978, 189:92-96.
128. Mistry M., Nasjletti A. Prostanoids as mediators of prohypertensive and antihypertensive mechanisms. Am J Med Sci 1988, 295:263-267.
129. Moeckel G.W., Zhang L., Fogo A.B., et al. COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress. J Biol Chem 2003, 278:19352-19357.
130. Moghaddam M., Motoba K., Borhan B., et al. Novel metabolic pathways for linoleic and arachidonic acid metabolism. Biochim Biophys Acta 1996, 1290:327-339.
131. Morham S.G., Langenbach R., Loftin C.D., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995, 83:473-482.
132. Morrison A.R., Pascoe N. Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex. Proc Natl Acad Sci U S A 1981, 78:7375-7378.
133. Muirhead E.E., Pitcock J.A., Nasjletti A., et al. The antihypertensive function of the kidney. Its elucidation by captopril plus unclipping. Hypertension 1985, 7. I127-I135.
134. Muller D.N., Theuer J., Shagdarsuren E., et al. A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol 2004, 164:521-532.
135. Munger K.A., Montero A., Fukunaga M., et al. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc Natl Acad Sci U S A 1999, 96:13375-13380.
136. 2. J Biol Chem 1997, 272:19891-19897.
137. Murakami M., Naraba H., Tanioka T., et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000, 275:32783-32792.
138. Nakagawa K., Marji J.S., Schwartzman M.L., et al. Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1055-R1062.
139. Natarajan R., Gerrity R.G., Gu J.L., et al. Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 2002, 45:125-133.
140. Navar L.G., Inscho E.W., Majid S.A., et al. Paracrine regulation of the renal microcirculation. Physiol Rev 1996, 76:425-536.
141. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenasederived eicosanoids. Science 1999, 285:1276-1279.
142. Node K., Ruan X.L., Dai J., et al. Activation of G alphas mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 2001, 276:15983-15989.
143. Novy M.J. Effects of indomethacin on labor, fetal oxygenation, and fetal development in rhesus monkeys. Adv Prostaglandin Thromboxane Res 1978, 4:285-300.
144. Nowicki S., Chen S.L., Aizman O., et al. 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase. J Clin Invest 1997, 99:1224-1230.
145. Ogletree M.L., Harris D.N., Greenberg R., et al. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 1985, 234:435-441.
146. Oliw E.H., Guengerich F.P., Oates J.A. Oxygenation of arachidonic acid by hepatic monooxygenases: isolation and metabolism of four epoxide intermediates. J Biol Chem 1982, 257:3771-3781.
147. Olsen U.B. Diuretics and kidney prostaglandins. Prostaglandins and the Kidney 1983, 205-212. Plenum Medical Book Company, New York and London. M.J. Dunn, C. Patrono, G.A. Cinotti (Eds.).
148. Oltman C.L., Weintraub N.L., VanRollins M., et al. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 1998, 83:932-939.
149. Omata K., Abraham N.G., Schwartzman M.L. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am J Physiol 1992, 262:F591-F599.
150. Ominato M., Satoh T., Katz A.I. Regulation of Na-K-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J Membr Biol 1996, 152:235-243.
151. Orloff J., Grantham J. The effect of prostaglandin (PGE1) on the permeability response of rabbit collecting tubules to vasopressin. Prostaglandins: Proceedings of the Second Nobel Symposium 1966, 143-146. John Wiley & Sons, New York. S. Bergstrom, B. Samuelsson (Eds.).
152. Oyekan A., Balazy M., McGiff J.C. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol 1997, 273:R293-R300.
153. Oyekan A.O., McGiff J.C. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol 1998, 274:R52-R61.
154. Oyekan A.O., McGiff J.C. Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome p450-derived arachidonate metabolites. Br J Pharmacol 1998, 125:1065-1073.
155. Palmer B.F. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004, 351:585-592.
156. Piper P.J., Vane J.R. Release of additional factors in anaphylaxis and its antagonism by antiinflammatory drugs. Nature 1969, 223:29-35.
157. Pomposiello S.I., Carroll M.A., Falck J.R., et al. Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR. Hypertension 2001, 37:887-893.
158. Prakash C., Zhang J.Y., Falck J.R., et al. 20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem Biophys Res Commun 1992, 185:728-733.
159. Pugliese F., Ciabattoni G. Investigations of renal arachidonic acid metabolites by radioimmunoassay. Prostaglandins and the Kidney 1983, 83-98. Plenum Medical Books, New York. M.J. Dunn, C. Patrono, G.A. Cinotti (Eds.).
160. Qi Z., Hao C.M., Langenbach R.I., et al. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 1902, 110:61-69.
161. Quigley R., Baum M., Reddy K.M., et al. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. Am J Physiol Renal Physiol 1900, 278:F949-F953.
162. Quilley J., Fulton D., McGiff J.C. Hyperpolarizing factors. Biochem Pharmacol 1997, 54:1059-1070.
163. Quilley J., McGiff J.C. Influence of insulin on urinary eicosanoid excretion in rats with experimental diabetes mellitus. J Pharmacol Exp Ther 1986, 238:606-611.
164. Quilley J., McGiff J.C., Nasjletti A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br J Pharmacol 1989, 96:111-116.
165. Randriamboavonjy V., Kiss L., Falck J.R., et al. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc Res 2005, 65:487-494.
166. Reckelhoff J.F., Granger J.P. Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 1999, 26:127-131.
167. Reddy M.A., Thimmalapura P.R., Lanting L., et al. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation: mediation of angiotensin II effects. J Biol Chem 2002, 277:9920-9928.
168. Reimann I.W., Fischer C., Rosenkranz B., et al. Investigations on renal prostaglandins by gas chromatography-mass spectrometry. Prostaglandins and the Kidney 1983, 99-107. Plenum Medical Books, New York. M.J. Dunn (Ed.).
169. Reinhold S.W., Vitzthum H., Filbeck T., et al. Gene expression of 5-, 12- and 15-lipoxygenases and leukotriene receptors along the rat nephron. Am J Physiol Renal Physiol 2006, 290:F864-F872.
170. Ren Y., Garvin J.L., Carretero O.A. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int 2001, 59:222-229.
171. Ribeiro C.M., Dubay G.R., Falck J.R., et al. Parathyroid hormone inhibits Na(+)-K(+)-ATPase through a cytochrome P-450 pathway. Am J Physiol 1994, 266:F497-F505.
172. Riccardi D., Hall A.E., Chattopadhyay N., et al. Localization of the extracellular Ca2+/ polyvalent cation-sensing protein in rat kidney. Am J Physiol 1998, 274:F611-F622.
173. Robert A., Nezamis J.E., Lancaster C., et al. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979, 77:433-443.
174. Rodriguez F., Llinas M.T., Gonzalez J.D., et al. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension 2000, 36:276-281.
175. Rodriguez J.A., Vio C.P., Pedraza P.L., et al. Bradykinin regulates cyclooxygenase-2 in rat renal thick ascending limb cells. Hypertension 2004, 44:230-235.
176. Roig F., Llinas M.T., Lopez R., et al. Role of cyclooxygenase-2 in the prolonged regulation of renal function. Hypertension 2002, 40:721-728.
177. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002, 82:131-185.
178. Roman R.J., Ma Y.H., Frohlich B., et al. Clofibrate prevents the development of hypertension in Dahl salt- sensitive rats. Hypertension 1993, 21:985-988.
179. Romero M.F., Hopfer U., Madhun Z.T., et al. Angiotensin II actions in the rabbit proximal tubule. Angiotensin II mediated signaling mechanisms and electrolyte transport in the rabbit proximal tubule. Ren Physiol Biochem 1991, 14:199-207.
180. Romero M.F., Madhun Z.T., Hopfer U., et al. An epoxygenase metabolite of arachidonic acid 5,6 epoxy- eicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium. Adv Prostaglandin Thromboxane Leukot Res 1991, 21A:205-208.
181. Rosenblatt S.G., Patak R.V., Lifschitz M.D. Organic acid secretory pathway and urinary excretion of prostaglandin E in the dog. Am J Physiol 1978, 235:F473-F479.
182. Rzigalinski B.A., Willoughby K.A., Hoffman S.W., et al. Calcium influx factor, further evidence it is 5, 6-epoxyeicosatrienoic acid. J Biol Chem 1999, 274:175-182.
183. Sacerdoti D., Balazy M., Angeli P., et al. Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. J Clin Invest 1997, 100:1264-1270.
184. Sakairi Y., Jacobson H.R., Noland T.D., et al. 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am J Physiol 1995, 268:F931-F933.
185. Salmon J.A., Smith D.R., Flower R.J., et al. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Biochim Biophys Acta 1978, 523:250-262.
186. Samuelsson B. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982. Biosci Rep 1983, 3:791-813.
187. Schneider A., Zhang Y., Zhang M., et al. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. Kidney Int 2004, 65:1205-1213.
188. Schnermann J. Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol 1998, 274:R263-R279.
189. Schnermann J., Schubert G., Hermle M., et al. The effect of inhibition of prostaglandin synthesis on tubuloglomerular feedback in the rat kidney. Pflugers Arch 1979, 379:269-279.
190. Schreiner G.F., Kohan D.E. Regulation of renal transport processes and hemodynamics by macrophages and lysmphocytes. Am J Physiol 1990, 258:F761-F767.
191. Schwartzman M., Carroll M.A., Ibraham N.G., et al. Renal arachidonic acid metabolism. The third pathway. Hypertension 1985, 7. I136-I144.
192. Schwartzman M.L., Abraham N.G., Carroll M.A., et al. Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem J 1986, 238:283-290.
193. Schwartzman M.L., Falck J.R., Yadagiri P., et al. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. Biol Chem 1989, 264:11658-11662.
194. Schwartzman M.L., McGiff J.C. Renal cytochrome P450. J Lipid Mediat Cell Signal 1995, 12:229-242.
195. Sinal C.J., Miyata M., Tohkin M., et al. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 2000, 275:40504-40510.
196. Smith J.A., Whitaker E.M., Yaktubay N., et al. Regulation of renal adenosine A(1) receptors: effect of dietary sodium chloride. Eur J Pharmacol 1999, 384:71-79.
197. Smith W.L. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992, 263:F181-F191.
198. Smith W.L., Bell T.G. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol 1978, 235:F451-F457.
199. Smith W.L., DeWitt D.L. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 1996, 62:167-215.
200. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000, 69:145-182.
201. Smith W.L., Wilkin G.P. Immunochemistry of prostaglandin endoperoxide-forming cyclooxygenases: the detection of the cyclooxygenases in rat, rabbit, and guinea pig kidneys by immunofluorescence. Prostaglandins 1977, 13:873-892.
202. Sonnenburg W.K., Smith W.L. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins. J Biol Chem 1988, 263:6155-6160.
203. Sonnenburg W.K., Zhu J.H., Smith W.L. A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. J Biol Chem 1990, 265:8479-8483.
204. Spector A.A., Fang X., Snyder G.D., et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 2004, 43:55-90.
205. Spiecker M., Liao J.K. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 2005, 433:413-420.
206. Sraer J., Foidart J., Chansel D., et al. Prostaglandin synthesis by mesangial and epithelial glomerular cultured cells. FEBS Lett 1979, 104:420-424.
207. Steinhauslin F., Munafo A., Buclin T., et al. Renal effects of nimesulide in furosemide-treated subjects. Drugs 1993, 46(Suppl 1):257-262.
208. Stokes J.B. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. Selective inhibitions of the medullary portion. J Clin Invest 1979, 64:495-502.
209. + channel activity and vascular tone in renal arterioles. Circ Res 1998, 83:1069-1079.
210. Sun F.F., Taylor B.M., McGuire J.C., et al. Metabolic disposition of prostacyclin. Prostacyclin 1979, 119-131. Raven Press, New York. J.R.B.S. Vane (Ed.).
211. Swan S.K., Rudy D.W., Lasseter K.C., et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: a randomized, controlled trial. Ann Intern Med 2000, 133:1-9.
212. Takizawa H., DelliPizzi A.M., Nasjletti A. Prostaglandin I2 contributes to the vasodepressor effect of baicalein in hypertensive rats. Hypertension 1998, 31:866-871.
213. Terragno N.A., Terragno D.A., McGiff J.C. Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dogs. Circ Res 1977, 40:590-595.
214. Terragno N.A., Terragno D.A., Pacholczyk D., et al. Prostaglandins and the regulation of uterine blood flow in pregnancy. Nature 1974, 249:57-58.
215. Thorup C., Persson A.E. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol 1994, 267:F606-F611.
216. van der Heijden B.J., Carlus C., Narcy F., et al. Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 1994, 171:617-623.
217. Vargas-Poussou R., Huang C., Hulin P., et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002, 13:2259-2266.
218. Vio C.P., An S.J., Cespedes C., et al. Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy. J Am Soc Nephrol 1901, 12:649-658.
219. Vio C.P., Cespedes C., Gallardo P., et al. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 1997, 30:687-692.
220. von Euler U.S. Welcoming address. Prostaglandins: Proceedings of the Second Nobel Symposium 2006, 16-20. John Wiley & Sons, New York. B.S. Bergstrom (Ed.).
221. Wang D., An S.J., Wang W.H., et al. CaR-mediated COX-2 expression in primary cultured mTAL cells. Am J Physiol Renal Physiol 2001, 281:F658-F664.
222. Wang D., Chabrashvili T., Wilcox C.S. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothe. Circ Res 2004, 94:1436-1442.
223. Wang D., Pedraza P.L., Abdullah H.I., et al. Calcium-sensing receptor-mediated TNF production in medullary thick ascending limb cells. Am J Physiol Renal Physiol 2002, 283:F963-F970.
224. Wang H., Garvin J.L., Falck J.R., et al. Glomerular cytochrome P-450 and cyclooxygenase metabolites regulate efferent arteriole resistance. Hypertension 2005, 46:1175-1179.
225. Wang J.L., Cheng H.F., Harris R.C. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 1999, 34:96-101.
226. + channel in the thick ascending limb of the rat kidney. J Gen Physiol 1995, 106:727-743.
227. Watanabe S., Fukumoto S., Chang H., et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002, 360:692-694.
228. Wei Y., Lin D.H., Kemp R., et al. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways. J Gen Physiol 2004, 124:719-727.
229. Welch W.J., Wilcox C.S. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J Clin Invest 1992, 89:1857-1865.
230. Whisenant N., Zhang B.X., Khademazad M., et al. Regulation of Na-K-2Cl cotransport in osteoblasts. Am J Physiol 1991, 261:C433-C440.
231. Wilcox C.S., Welch W.J., Murad F., et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A 1992, 89:11993-11997.
232. Wong P.Y.-K., Sun F.F., Malik K.U., Vane J.R.B.S., et al. Metabolism of prostacyclin (PGI2) in the isolated kidney and lung of the rabbit. Proceedings of the Workshop on Prostacyclin and Its Analogues 1979, 133-145. Raven Press, New York.
233. Wong P.Y., McGiff J.C., Cagen L., et al. Metabolism of prostacyclin in the rabbit kidney. J Biol Chem 1979, 254:12-14.
234. Wong P.Y., McGiff J.C., Sun F.F., et al. Pulmonary metabolism of prostacyclin (PGI2) in the rabbit. Biochem Biophys Res Commun 1978, 83:731-738.
235. Wong P.Y., Sun F.F., McGiff J.C. Metabolism of prostacyclin in blood vessels. J Biol Chem 1978, 253:5555-5557.
236. Xie W.L., Chipman J.G., Robertson D.L., et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 1991, 88:2692-2696.
237. Yang T., Huang Y., Heasley L.E., et al. MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. J Biol Chem 2000, 275:23281-23286.
238. Yang T., Park J.M., Arend L., et al. Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. J Biol Chem 2000, 275:37922-37929.
239. Yang T., Singh I., Pham H., et al. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol 1998, 274:F481-F489.
240. Yard B.A., Daha M.R., Kooymans-Couthino M., et al. IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells. Kidney Int 1992, 42:383-389.
241. Yiu S.S., Zhao X., Inscho E.W., et al. 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels. J Lipid Res 2003, 44:2391-2399.
242. Yu M., Cambj-Sapunar L., Kehl F., et al. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol 2004, 486:297-306.
243. Yu Z., Huse L.M., Adler P., et al. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. Mol Pharmacol 2000, 57:1011-1020.
244. Yu Z., Xu F., Huse L.M., et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 2000, 87:992-998.
245. Yue Q.Y., Odar-Cederlof I., Svensson J.O., et al. Glucuronidation of morphine in human kidney microsomes. Pharmacol Toxicol 1988, 63:337-341.
246. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001, 276:36059-36062.
247. Zewde T., Mattson D.L. Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension 2004, 44:424-442.
248. Zhang F., Deng H., Kemp R., et al. Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats. Hypertension 2005, 45:103-108.
249. Zhang F., Wang M.H., Krishna U.M., et al. Modulation by 20-HETE of phenylephrineinduced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 2001, 38:1311-1315.
250. Zhang F., Wang M.H., Wang J.S., et al. Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli. Am J Physiol Heart Circ Physiol 2004, 287:H1089-H1095.
251. Zhang J.Y., Prakash C., Yamashita K., et al. Regiospecific and enantioselective metabolism of 8,9- epoxyeicosatrienoic acid by cyclooxygenase. Biochem Biophys Res Commun 1992, 183:138-143.
252. Zhang M.Z., Wang J.L., Cheng H.F., et al. Cyclooxygenase-2 in rat nephron development. Am J Physiol 1997, 273:F994-F1002.
253. Zhang Y.B., Magyar C.E., Holstein-Rathlou N.H., et al. The cytochrome P-450 inhibitor cobalt chloride prevents inhibition of renal Na,K-ATPase and redistribution of apical NHE-3 during acute hypertension. J Am Soc Nephrol 1998, 9:531-537.
254. Zhao X., Inscho E.W., Bondlela M., et al. The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. Am J Physiol Heart Circ Physiol 2001, 281:H2089-H2096.
255. Zhao X., Pollock D.M., Inscho E.W., et al. Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension 2003, 41:709-714.
256. Zhu D., Zhang C., Medhora M., et al. CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. J Appl Physiol 2002, 93:330-337.
257. Zou A.P., Fleming J.T., Falck J.R., et al. 20-HETE is an endogenous inhibitor of the largeconductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol 1996, 270:R228-R237.
258. Zou A.P., Fleming J.T., Falck J.R., et al. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity. Am J Physiol 1996, 270:F822-F832.
259. Zou A.P., Imig J.D., Kaldunski M., et al. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 1994, 266:F275-F282.
260. Zou A.P., Imig J.D., Ortiz de Montellano P.R., et al. Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol 1994, 266:F934-F941.
261. Zusman R.M., Caldwell B.V., Speroff L., et al. Radioimmunoassay of the A prostaglandins. Prostaglandins 1972, 2:41-45.